Bionure Farma SL   Report issue

For profit Phase 1
Founded: Menlo Park CA United States (2009)
Status: Defunct (2020)

Organization Overview

First Clinical Trial
2018
NCT03630497
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Bionure Farma SL

Active Ingredients

Drugs in Phase 1 Trials (1)

bn201 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Demyelinating Diseases (Phase 1)

Neuritis (Phase 1)

Optic Neuritis (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 1
  • # of Trial APIs: 1